Trustco Bank Corp N Y
Cannabis Sector Marks Third Straight Day of Decline
The downward momentum in cannabis stocks has continued today, marking the third straight day of decline for the cannabis sector.
Did the Cannabis Sector Bottom Out in 2019?
This year was tough for the cannabis sector, especially given that the S&P 500 was making new highs. The S&P 500 hit a new high of 3,247.93 on December 27.
Cannabis Sector 2019 Review and 2020 Outlook
Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.
CannTrust Receives NYSE Listing Compliance Notice
Beleaguered cannabis company CannTrust (CTST)(TRST) received a notice from the NYSE that the company is no longer in compliance with its listing rules.
Cannabis Update: HEXO, CTST, APHA, and ACB
At 12:51 PM ET, the S&P 500 Index and the Dow Jones Industrial Average were up 0.5% and 0.7%, respectively. The cannabis sector was also up today.
The Next Big Breakout Beverage Market Has Been Identified
Discover the under-the-radar Canadian company that is positioned to lead the upcoming wave of cannabis-infused beverages, BevCanna!
Cannabis Stocks in the Green: APHA, WEED, CTST, ACB
With a boost from Aphria’s (APHA) impressive first-quarter earnings, cannabis stocks and ETFs were trading higher today. Let’s take a closer look.
Cannabis Roundup: HEXO, WEED, ACB, and CTST
The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.
HEXO: The Next Cannabis Player on the Scandal Radar?
By the end of September, HEXO was one of the few cannabis companies to have delivered positive returns in 2019. However, this month has been tough.
Cannabis Scandal Radar: Is Tilray Next?
Scandals have engulfed the sector many times, especially for CannTrust, Curaleaf, and Hexo. Could Tilray be next on the cannabis scandal radar?
Cannabis Stocks: Will Tough Times End Soon?
Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.
Cannabis Roundup: KSHB, WEED, CTST, and CURA
Today, President Trump announced that a US-China trade deal could happen earlier than expected. Equities were up, but cannabis stocks were mixed.
CannTrust Stock Hits an All Time Low: What’s Next?
CannTrust (CTST) (TRST) was one of the worst performers in the cannabis sector last week. The stock lost almost 19.6% in one week alone.
Which Cannabis Stocks Have Lost More than 40% in 2019?
The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.
Marijuana Legalization: O’Rourke Blazes His 2020 Campaign
Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.
Cannabis Roundup: CTST, CURA, CRON, and WEED
Today, the US cannabis markets were trading a little higher than we have seen in the recent past. The Federal Reserve cut interest rates by 25 points.
Canopy Growth Stock Rises, Oppenheimer Initiates Coverage
Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.
Cannabis: House to Vote on US Banking Bill
The SAFE Banking Act is gaining traction again, as House Majority Leader Steny Hoyer is expected to bring the banking bill to the House floor for a vote.
CannTrust Loses License: Will It Fall below $1?
CannTrust reported that its license under the Cannabis Act was suspended. The company won’t be able to produce cannabis. Will CannTrust fall below $1?.
Cannabis Roundup: MMEN, ACB, WEED, and CTST
Today at 2:10 PM ET, the S&P 500 Index fell 0.3% as investors watched rising oil prices. The cannabis sector also fell today, as its ETFs traded in the red.
Cannabis Legalization: Dark Clouds Loom Post Debate
Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.
CannTrust: Eight Capital Removed Its Target Price
On Tuesday, Eight Capital removed its target price for CannTrust Holdings due to uncertainty about the risks involved in the company’s future operations.
CannTrust Down Almost 65% in 2019—What’s Next?
On September 6, CannTrust Holdings (TRST) (CTST) was trading at 2.33 Canadian dollars. This marked a discount of 85% from its 52-week high.
Cannabis Roundup: CTST, CRON, OGI, ACB, and WEED
Cannabis ETFs the ETFMG Alternative Harvest ETF and the Horizons Marijuana Life Sciences Index ETF were up 2.0% and 1.7%, respectively, at 1:20 PM today.
HEXO: What’s the Word on the Street?
HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.
How Cannabis ETFs HMMJ, MJ, TOKE Looked in August
In the wake of its regulatory scandals, the cannabis sector lagged the equity market in August. YTD, MJ and HMMJ have fallen 3.7% and 1.5%, respectively.
Cannabis Legalization: Did President Trump Drop a Hint?
Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.
Marijuana: Why Is Washington Changing Its Laws?
In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.
OrganiGram: Lower Target Price and Valuation Multiple
Analysts expect OrganiGram to report revenues of 96.9 million Canadian dollars in fiscal 2019 and 206.5 million Canadian dollars in 2020.
Canopy Growth Gets an Upgrade, Constellation Books Losses
Canopy Growth (CGC) (WEED) received optimistic views from analysts on Monday. Seaport Global Securities upgraded the stock to “buy” from “neutral.”
Kamala Harris on Legalizing Marijuana and ‘MORE’
Initially, Kamala Harris was against cannabis legalization. In 2010, she opposed Proposition 19 while serving as California’s attorney general.
Cresco Labs: Target Price and Valuation Multiple
Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”
HEXO: What Does Jim Cramer Think?
HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.
CannTrust: Why Has the Stock Fallen Today?
CannTrust Holdings’ (TRST) troubles continue to rise. Today, OCS announced that it will return $2.9 million worth of products to the company.
Why Has Curaleaf Lost 13.5% in August?
As of August 17, Curaleaf Holdings (CURA) (CURLF) was trading at 9.00 Canadian dollars—a fall of 13.5% in August.
Aurora Cannabis’s Target Price and Valuation
Despite Aurora Cannabis providing higher-than-expected guidance for fiscal 2019’s fourth quarter early this year, its stock has fallen 25.6% this month.
CannTrust: Current Target Price and Valuation Multiple
As of Monday, CannTrust was trading at 3.04 Canadian dollars. The company has lost 53.6% of its stock value since the beginning of July.
Considerations for Investors in Marijuana or Cryptocurrencies
The forecasting of future cash flows depends on the market potential for legalized medical and recreational marijuana.